Benazepril Hydrochloride and Hydrochlorothiazide - benazepril hydrochloride and hydrochlorothiazide
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-4725 |
| Proprietary Name: | Benazepril Hydrochloride and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | benazepril hydrochloride and hydrochlorothiazide |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 03-12-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA076688 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
| Active Numerator Strength: | 5; 6.25 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |